Clene Inc.
CLNN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -44.4% | -66.7% | -11% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 75.3% | 80.2% |
| R&D Expenses | $4 | $4 | $1 | $6 |
| G&A Expenses | $2 | $2 | $3 | $3 |
| SG&A Expenses | $2 | $2 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6 | $6 | $4 | $9 |
| Operating Income | -$6 | -$6 | -$4 | -$9 |
| % Margin | -37,653.3% | -21,718.5% | -5,032.1% | -9,511% |
| Other Income/Exp. Net | -$3 | -$2 | $3 | -$5 |
| Pre-Tax Income | -$9 | -$7 | -$1 | -$14 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$7 | -$1 | -$14 |
| % Margin | -58,513.3% | -27,477.8% | -927.2% | -14,889% |
| EPS | -0.85 | -0.78 | -0.085 | -1.95 |
| % Growth | -9% | -816.6% | 95.6% | – |
| EPS Diluted | -0.85 | -0.78 | -0.085 | -1.95 |
| Weighted Avg Shares Out | 10 | 10 | 9 | 7 |
| Weighted Avg Shares Out Dil | 10 | 10 | 9 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$6 | $0 | -$13 |
| % Margin | -51,753.3% | -23,607.4% | 322.2% | -13,876.9% |